<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Estradiol regulation in porto-sinusoidal vascular disease" Data-Source="WikiPathways" Version="WP5235_r140106" Author="[ChristeldeVries, Fehrhart, AlexanderPico, Egonw, Eweitz, Larsgw, Khanspers]" Last-Modified="20250727065244" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Porto-sinusoidal vascular disease (PSVD) is a rare disease (Schouten et al., 2015), affecting less than 1 in 2000 citizens (European standard) (Griffon et al., 2016). It is characterized by signs of presinusoidal portal hypertension without cirrhosis, where the cause of the hypertension is unknown (Lee et al., 2016; Schouten et al., 2011). Based on that what is known about the etiology of PSVD, its development can be categorized into five groups: immunological disorders, chronic infections, exposure to medications or toxins, prothrombic conditions, and genetic predisposition (Schouten et al., 2015). In practice, the disease has multiple contributing factors (Siramolpiwat et al., 2016). 

This pathway describes a mutation in the KCNN3 gene that is hypothesized to result in genetic predisposition to PSVD (Koot et al., 2016). PSVD has also been referred as idiopathic non-cirrhotic portal hypertension (INCPH), hepatoportal sclerosis, incomplete septal cirrhosis, obliterative portal venopathy, partial nodular transformation, non-cirrhotic portal fibrosis, nodular regenerative hyperplasia (NRH), and idiopathic portal hypertension (Schouten et al., 2015; Siramolpiwat et al., 2016; Besmond et al., 2017).</Comment>
  <BiopaxRef>d2a</BiopaxRef>
  <BiopaxRef>c52</BiopaxRef>
  <BiopaxRef>b38</BiopaxRef>
  <BiopaxRef>b9e</BiopaxRef>
  <BiopaxRef>a58</BiopaxRef>
  <BiopaxRef>b60</BiopaxRef>
  <BiopaxRef>f5b</BiopaxRef>
  <Graphics BoardWidth="658.75" BoardHeight="621.25" />
  <DataNode TextLabel="Endothelial hyperpolarization" GraphId="c427e">
    <BiopaxRef>c18</BiopaxRef>
    <BiopaxRef>c46</BiopaxRef>
    <Graphics CenterX="147.99404761904452" CenterY="449.8277116402121" Width="177.19444444444434" Height="25.56018518518431" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Wikidata" ID="Q1355864" />
  </DataNode>
  <DataNode TextLabel="KCNN3" GraphId="de4dc" Type="GeneProduct">
    <Comment>A single nucleotide substitution (SNP) c.1348G&gt;C in the KCNN3 gene was found in a father with INCPH and three of his children that were tested with Sanger- and whole-exome sequencing. These three children had developed signs of INCPH in the first ten years of their lives. A full sister of one of the girls had no complaints and did not participate in the examinations. Ultrasound and liver tests of the paternal grandparents showed no abnormalities of the liver. (Koot et al. 2015)&#xD;
&#xD;
KCNN genes are expressed in neurons, epithelium, endothelium of the vasculature, and several types of smooth muscle. The SK3 channel, which is a gene product of the KCNN3 gene, is involved in vascular tone- and blood pressure regulation. &#xD;
&#xD;
Calcium-induced activation of the SK3 channel will cause hyperpolarization of endothelial cells, resulting in hyperpolarization of the adjacent muscle cell, which is also known as an endothelium-derived hyperpolarizing factor (EDHF). This hyperpolarization of the muscle cells will then result in dilation in resistance arteries (Ledoux et al. 2006; Kohler et al. 2010). &#xD;
The level of SK3 channel expression in endothelial cells was found to be important for vascular tone and blood pressure in mice. (Taylor et al. 2003)&#xD;
&#xD;
Gene transcription:&#xD;
Two binding sites for the SP1 and SP3 transcription factors are present in the promotor region of the KCNN3 gene in mice. SP1 and SP3 compete to regulate the expression of the KCNN3 gene, influenced by the environment of the promotors. SP1 activates the expression of the gene, and SP3 inhibits the expression of the gene (Pierce et al., 2010; Xiong et al., 2020) . It was found that ERα stimulates the transcription KCNN3 through these transcription factors (Jacobson et al., 2003).&#xD;
</Comment>
    <BiopaxRef>b9e</BiopaxRef>
    <BiopaxRef>c18</BiopaxRef>
    <BiopaxRef>c46</BiopaxRef>
    <BiopaxRef>f2f</BiopaxRef>
    <BiopaxRef>c6d</BiopaxRef>
    <BiopaxRef>a0e</BiopaxRef>
    <Graphics CenterX="228.12171583842462" CenterY="157.9367448471932" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Ensembl" ID="ENSG00000143603" />
  </DataNode>
  <DataNode TextLabel="ESR1" GraphId="e04f4" Type="Protein">
    <BiopaxRef>a0e</BiopaxRef>
    <Graphics CenterX="401.4014794176903" CenterY="200.74211263490122" Width="54.05349794238681" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P03372" />
  </DataNode>
  <DataNode TextLabel="Ca²⁺" GraphId="e6040" Type="Metabolite">
    <Graphics CenterX="375.4098596028374" CenterY="301.0471903253724" Width="47.13219616204678" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="SP1" GraphId="ea371" Type="Protein" GroupRef="bf87b">
    <BiopaxRef>c6d</BiopaxRef>
    <Graphics CenterX="323.2359568077362" CenterY="200.74211263490122" Width="43.09993324038828" Height="23.894353266407634" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P08047" />
  </DataNode>
  <DataNode TextLabel="Apamin" GraphId="f0914" Type="Metabolite">
    <Comment>The SK3 channel is apamin sensitive. The peptide toxin apamin, present in bee venom, blocks the SK3 channels, reducing hyperpolarization of the cells (Morikawa, 2010; Weisbrod, 2020)
</Comment>
    <BiopaxRef>aa5</BiopaxRef>
    <BiopaxRef>cd9</BiopaxRef>
    <Graphics CenterX="430.80462907084086" CenterY="426.996434511678" Width="90.0" Height="26.543550165380566" ZOrder="32768" FontSize="12" Valign="Middle" Color="0000ff" />
    <Xref Database="PubChem-compound" ID="16133797" />
  </DataNode>
  <DataNode TextLabel="Estradiol" GraphId="f8b8f" Type="Metabolite">
    <Comment></Comment>
    <Graphics CenterX="401.8595646215391" CenterY="137.04550035768176" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:16469" />
  </DataNode>
  <DataNode TextLabel="K⁺" GraphId="fc6c6" Type="Metabolite" GroupRef="ed712">
    <Graphics CenterX="298.8754471817066" CenterY="301.0471903253724" Width="44.999999999999694" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29103" />
  </DataNode>
  <DataNode TextLabel="SP3" GraphId="fcc8b" Type="Protein" GroupRef="bf87b">
    <BiopaxRef>c6d</BiopaxRef>
    <Graphics CenterX="269.66835271583693" CenterY="242.92616068427873" Width="42.424242424243594" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q02447" />
  </DataNode>
  <DataNode TextLabel="SK3" GraphId="be6d4" Type="Protein" GroupRef="bddf4">
    <Comment>Also referred to as:&#xD;
Small-conductance Ca2+- activated K+ (SK) channel&#xD;
Small conductance calcium-activated potassium channel protein 3&#xD;
SK3 channel&#xD;
SKCa 3&#xD;
KCa channel&#xD;
&#xD;
About:&#xD;
The SK3 channel is important for afterhyperpolarization following an action potential. One channel is made from four monomers which all contain six transmembrane segments,  connected via a single pore loop. The N-termini and the C-termini are both located at the intracellular side of the membrane. A calmodulin molecule is located at the C-termini of the SK3 channel via a CaM-binding domain. Calmodulin will activate the SK3 channel upon binding of Ca²⁺. SK3 channels are not voltage-dependent. (Gu et al. 2018; Köhler et al. 1996; Weisbrod, 2020)&#xD;
&#xD;
Calcium-induced activation of the SK3 channel will cause hyperpolarization of endothelial cells, resulting in hyperpolarization of the adjacent muscle cell, which is also known as an endothelium-derived hyperpolarizing factor (EDHF). This hyperpolarization of the muscle cells will then result in dilation in resistance arteries (Ledoux et al. 2006; Kohler et al. 2010). &#xD;
The level of SK3 channel expression in endothelial cells was found to be important for vascular tone and blood pressure in mice. (Taylor et al. 2003)&#xD;
</Comment>
    <BiopaxRef>ca7</BiopaxRef>
    <BiopaxRef>c33</BiopaxRef>
    <BiopaxRef>cd9</BiopaxRef>
    <BiopaxRef>c18</BiopaxRef>
    <BiopaxRef>c46</BiopaxRef>
    <BiopaxRef>f2f</BiopaxRef>
    <Graphics CenterX="298.8754471817066" CenterY="390.474764646685" Width="60.0" Height="25.0" ZOrder="32909" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q9UGI6" />
  </DataNode>
  <DataNode TextLabel="CALM1" GraphId="d18c5" Type="Protein" GroupRef="bddf4">
    <Graphics CenterX="298.8754471817066" CenterY="365.474764646685" Width="60.0" Height="25.0" ZOrder="32910" FontSize="12" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P0DP23" />
  </DataNode>
  <DataNode TextLabel="K+" GraphId="a3bab" Type="Metabolite" GroupRef="ed712">
    <Graphics CenterX="298.8754471817065" CenterY="450.3214285714282" Width="44.999999999999694" Height="25.0" ZOrder="32911" FontSize="12" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29103" />
  </DataNode>
  <DataNode TextLabel="Endothelial derived hyperpolarization (EDH) &#xA;of vascular smooth muscle cells" GraphId="bdffa">
    <Graphics CenterX="166.98082010581788" CenterY="558.6197089947125" Width="250.0" Height="35.0" ZOrder="32921" FontSize="12" Valign="Middle" />
    <Xref Database="Wikidata" ID="Q1355864" />
  </DataNode>
  <DataNode TextLabel="Vascular dilation" GraphId="d8fb4">
    <BiopaxRef>c18</BiopaxRef>
    <BiopaxRef>c46</BiopaxRef>
    <Graphics CenterX="387.1494708994625" CenterY="558.6197089947124" Width="109.74074074074039" Height="25.0" ZOrder="32922" FontSize="12" Valign="Middle" />
    <Xref Database="Wikidata" ID="Q14859627" />
  </DataNode>
  <DataNode TextLabel="Lower blood pressure" GraphId="f8b32">
    <Graphics CenterX="542.7400793650759" CenterY="558.6197089947108" Width="130.0" Height="25.0" ZOrder="32923" FontSize="12" Valign="Middle" />
    <Xref Database="Wikidata" ID="Q275419" />
  </DataNode>
  <Interaction GraphId="id208fbda7">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="328.8754471817066" Y="365.474764646685" GraphRef="d18c5" RelX="1.0" RelY="0.0" />
      <Point X="328.8754471817066" Y="390.474764646685" GraphRef="be6d4" RelX="1.0" RelY="0.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id2f2bd2ac">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="301.6859901875421" Y="200.74211263490122" GraphRef="ea371" RelX="-1.0" RelY="0.0" />
      <Point X="228.12171583842462" Y="200.98778359511346" ArrowHead="mim-stimulation" />
      <Anchor Position="0.44611286050622573" Shape="None" GraphId="a6e49" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id565763e2">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="385.80462907084086" Y="426.996434511678" GraphRef="f0914" RelX="-1.0" RelY="0.0" />
      <Point X="313.8754471817066" Y="402.974764646685" GraphRef="be6d4" RelX="0.5" RelY="1.0" ArrowHead="mim-inhibition" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id5fc07f3f">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="428.4282283888837" Y="200.74211263490122" GraphRef="e04f4" RelX="1.0" RelY="0.0" />
      <Point X="344.78592342793036" Y="200.74211263490122" GraphRef="ea371" RelX="1.0" RelY="0.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id6435f0ab">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="401.8595646215391" Y="149.54550035768176" GraphRef="f8b8f" RelX="0.0" RelY="1.0" />
      <Point X="401.4014794176903" Y="188.24211263490122" GraphRef="e04f4" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id9486b09d">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="276.3754471817066" Y="450.3214285714282" GraphRef="a3bab" RelX="-1.0" RelY="0.0" />
      <Point X="236.5912698412667" Y="449.8277116402121" GraphRef="c427e" RelX="1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idbca2ebbf">
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="103.69543650793344" Y="462.60780423280426" GraphRef="c427e" RelX="-0.5" RelY="1.0" />
      <Point X="104.48082010581788" Y="541.1197089947125" GraphRef="bdffa" RelX="-0.5" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ideb9160ff" GroupRef="ed712">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="298.8754471817066" Y="313.5471903253724" GraphRef="fc6c6" RelX="0.0" RelY="1.0" />
      <Point X="298.8754471817065" Y="437.8214285714282" GraphRef="a3bab" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idebd4385f">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="375.4098596028374" Y="313.5471903253724" GraphRef="e6040" RelX="0.0" RelY="1.0" />
      <Point X="344.642653392272" Y="327.5" />
      <Point X="313.8754471817066" Y="352.974764646685" GraphRef="d18c5" RelX="0.5" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idf969b858">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="228.12171583842462" Y="170.4367448471932" GraphRef="de4dc" RelX="0.0" RelY="1.0" />
      <Point X="268.8754471817066" Y="384.224764646685" GraphRef="be6d4" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation" />
      <Anchor Position="0.08107709378666271" Shape="None" GraphId="ff18e" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idfb857ccd">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="269.66835271583693" Y="230.42616068427873" GraphRef="fcc8b" RelX="0.0" RelY="-1.0" />
      <Point X="268.8680213265925" Y="200.8517096097048" GraphRef="a6e49" RelX="0.0" RelY="0.0" ArrowHead="mim-inhibition" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="a2ec9">
    <Graphics ZOrder="32924" LineStyle="Broken" LineThickness="1.0">
      <Point X="291.9808201058179" Y="558.6197089947125" GraphRef="bdffa" RelX="1.0" RelY="0.0" />
      <Point X="332.27910052909226" Y="558.6197089947124" GraphRef="d8fb4" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="df394">
    <Graphics ZOrder="32925" LineStyle="Broken" LineThickness="1.0">
      <Point X="442.0198412698327" Y="558.6197089947124" GraphRef="d8fb4" RelX="1.0" RelY="0.0" />
      <Point X="477.74007936507587" Y="558.6197089947108" GraphRef="f8b32" RelX="-1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <GraphicalLine GraphId="id1efabc97">
    <Graphics ZOrder="12288" LineThickness="2.0">
      <Point X="101.90925589836661" Y="158.60798548094368" />
      <Point X="293.7462686567162" Y="159.57142857142856" />
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b3ae5">
    <Graphics ZOrder="32903" LineThickness="2.0">
      <Point X="102.03069367710248" Y="178.23634131368937" />
      <Point X="293.74098070552236" Y="179.1401780312852" />
    </Graphics>
  </GraphicalLine>
  <Label TextLabel="3 ' " GraphId="a6eb8">
    <Graphics CenterX="91.92139097556264" CenterY="157.55791079603216" Width="29.42786069651754" Height="20.005330490404283" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="Vascular endothelial cell (e.g. in resistance artery)" GraphId="c7fc4">
    <Graphics CenterX="301.1071428571389" CenterY="83.94047619047649" Width="368.7142857142778" Height="25.0" ZOrder="28672" FillColor="ffffff" FontStyle="Italic" FontSize="15" Valign="Middle" Color="999999" />
  </Label>
  <Label TextLabel="X" GraphId="fd0f2">
    <Comment>A familial case report, in which whole exome and Sanger sequencing were performed, suggested a that mutations in the KCNN3 gene could have a role in the development of INCPH (Koot et al.).</Comment>
    <Graphics CenterX="260.9762620460442" CenterY="158.13200096262864" Width="36.585365853658594" Height="25.98091198303291" ZOrder="32901" FillColor="ffffff" FontWeight="Bold" FontSize="20" Valign="Middle" Color="cc0000" />
  </Label>
  <Label TextLabel="3 ' " GraphId="fb226">
    <Graphics CenterX="311.2700781805254" CenterY="179.0952380952375" Width="90.0" Height="25.0" ZOrder="32904" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="5 '" GraphId="b97ed">
    <Graphics CenterX="90.25765085264868" CenterY="179.1075259559084" Width="30.046197583510857" Height="23.33155650319769" ZOrder="32905" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="5 '" GraphId="d7f99">
    <Graphics CenterX="308.96993388038084" CenterY="160.03799903799802" Width="90.0" Height="25.0" ZOrder="32906" FillColor="ffffff" FontSize="12" Valign="Middle" />
  </Label>
  <Label TextLabel="Vascular smooth muscle cell (e.g. in resistance artery)" GraphId="dd021">
    <Graphics CenterX="332.36185410844814" CenterY="516.0742757276339" Width="383.64947089946327" Height="25.0" ZOrder="32926" FillColor="ffffff" FontStyle="Italic" FontSize="15" Valign="Middle" Color="999999" />
  </Label>
  <Label TextLabel="Nucleus" GraphId="edb33">
    <Graphics CenterX="112.53873724356447" CenterY="252.01446605783957" Width="72.20881791354759" Height="16.18194179251244" ZOrder="32927" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" Color="999999" />
  </Label>
  <Shape GraphId="b4299">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="324.232" CenterY="226.44047619047632" Width="609.036" Height="332.88095238095264" ZOrder="-2" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape GraphId="c5c3b">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Nucleus" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="266.25" CenterY="188.75" Width="405.0" Height="162.5" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape GraphId="e437a">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="324.232" CenterY="542.1607142857143" Width="609.036" Height="98.17857142857133" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Group GroupId="bddf4" GraphId="cd4e4" Style="Complex" />
  <Group GroupId="fa3f6" GraphId="d7bdb" Style="Complex" />
  <Group GroupId="ed712" GraphId="e70a4" Style="Group" />
  <Group GroupId="a45d7" GraphId="f6a41" Style="Complex" />
  <InfoBox CenterX="0.0" CenterY="0.0" />
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c6d">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20682843</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SK3 channel expression during pregnancy is regulated through estrogen and Sp factor-mediated transcriptional control of the KCNN3 gene.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Am J Physiol Endocrinol Metab</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pierce SL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">England SK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c18">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">16443824</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Calcium-activated potassium channels and the regulation of vascular tone.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Physiology (Bethesda)</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2006</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ledoux J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Werner ME</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Brayden JE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nelson MT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aa5">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20813245</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Int Rev Neurobiol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Morikawa H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Morrisett RA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">portal hypertension</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DOID:10762</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f5b">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"></bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Idiopathic non-cirrhotic portal hypertension</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of Rare Diseases Research &amp; Treatment</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sith Siramolpiwat</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Susana Seijo</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c33">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8781233</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Small-conductance, calcium-activated potassium channels from mammalian brain.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Science</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1996</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Köhler M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hirschberg B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bond CT</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kinzie JM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Marrion NV</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maylie J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Adelman JP</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a0e">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12659870</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Determinants contributing to estrogen-regulated expression of SK3.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2003</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jacobson D</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pribnow D</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Herson PS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maylie J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Adelman JP</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d2a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26025214</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Idiopathic non-cirrhotic portal hypertension: a review.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Orphanet J Rare Dis</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schouten JN</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Verheij J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Seijo S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vascular associated smooth muscle cell</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CL:0000359</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">endothelial cell</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CL:0000115</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hypertension pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000021</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cd9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">33329039</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Small and Intermediate Calcium Activated Potassium Channels in the Heart: Role and Strategies in the Treatment of Cardiovascular Diseases.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Front Physiol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2020</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Weisbrod D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c46">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20349244</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Endothelial dysfunction and blood pressure alterations in K+-channel transgenic mice.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pflugers Arch</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Köhler R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ruth P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ca7">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">29651007</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Small-conductance Ca&lt;sup&gt;2+&lt;/sup&gt;-activated K&lt;sup&gt;+&lt;/sup&gt;channels: insights into their roles in cardiovascular disease.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Exp Mol Med</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2018</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gu M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhu Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yin X</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhang DM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c52">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27484923</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Searching for rare diseases in PubMed: a blind comparison of Orphanet expert query and query based on terminological knowledge.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">BMC Med Inform Decis Mak</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Griffon N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schuers M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dhombres F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Merabti T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kerdelhué G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rollin L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Darmoni SJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b9e">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26658685</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertension.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Hepatol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Koot BG</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Alders M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Verheij J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Beuers U</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cobben JM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a58">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26563701</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Idiopathic Noncirrhotic Portal Hypertension: An Appraisal.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Pathol Transl Med</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lee H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rehman AU</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fiel MI</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">disease pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000013</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f2f">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12805243</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Altered expression of small-conductance Ca2+-activated K+ (SK3) channels modulates arterial tone and blood pressure.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Circ Res</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2003</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Taylor MS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bonev AD</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gross TP</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eckman DM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Brayden JE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bond CT</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Adelman JP</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nelson MT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vascular disease</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DOID:178</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b60">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">21574171</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Idiopathic noncirrhotic portal hypertension.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hepatology</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schouten JN</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Garcia-Pagan JC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Valla DC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Janssen HL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b38">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">28792652</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mutations in the novel gene FOPV are associated with familial autosomal dominant and non-familial obliterative portal venopathy.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liver Int</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2018</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Besmond C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Valla D</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hubert L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Poirier K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Grosse B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Guettier C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bernard O</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gonzales E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jacquemin E</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>

